Heska Corporation (HSKA)
(Delayed Data from NSDQ)
$79.28 USD
+3.36 (4.43%)
Updated May 3, 2019 04:00 PM ET
After-Market: $79.10 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[HSKA]
Reports for Purchase
Showing records 1 - 20 ( 64 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Discontinuation of Research Coverage
Provider: Feltl & Company
Industry: Medical - Biomedical and Genetics
Heska once again blows away estimates ? raising target to $110.00
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Heska doubles up, again - raise target to $67.00, reiterate STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Heska puts doubters to sleep with Q2 results, guidance- raising target to $60.00
Provider: Feltl & Company
Analyst: HAYNOR B
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
We met with Kevin Wilson, Chief Executive Officer, for an update on Heska
Provider: G.RESEARCH, LLC
Analyst: TSAI J